Characterization Of Duvelisib In Patients With Refractory Marginal Zone Lymphoma: Data From The Phase 2 Dynamo Trial
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2019)
关键词
marginal zone lymphoma,PI3K,duvelisib,IBCL,indolent B-cell lymphoma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要